Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01627184 · ClinicalTrials.gov registry record
Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus
A clinical trial, sponsored by DexCom.
- Completed
- Registry status
- 13
- Enrollment target
NCT01627184 is a clinical trial that has completed, run by DexCom. The registered enrollment target is 13 participants.
The verdict
NCT01627184 has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate CGM glycemic control using the Dexcom G4 system as well as system performance during high levels of activity and home use by adult athletes with insulin-requiring diabetes mellitus, over an extended period of time.
Interventions
- DEVICE Dexcom G4 CGM System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01627184
The ClinicalTrials.gov registry entry for NCT01627184 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom G4 CGM System is the first listed.
NCT01627184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01627184 about?
NCT01627184 is a clinical study titled "Long-term Use: CGM System Assessment in Adult Athletes With Diabetes Mellitus". The purpose of this study is to evaluate CGM glycemic control using the Dexcom G4 system as well as system performance during high levels of activity and home use by adult athletes with insulin-requiring diabetes mellitus, over an extended period of time.
What is the current status of trial NCT01627184?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2012-05. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01627184?
The interventions under investigation include: Dexcom G4 CGM System (DEVICE).
Who is sponsoring clinical trial NCT01627184?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.